AGL
insider transactionsagilon health, inc. — buys & sells by directors, officers and 10% owners A shareholder owning more than 10% of the company. Must report trades, but usually a weaker signal than an officer or director. (SEC Form 4).
No open-market buys or sells this period. The trades below are grants, option exercises and gifts, which carry no market price.
Net buy / sell volume
Not enough data to chart yet.
Tap or hover the chart for daily net volume. Green = net buying, red = net selling.
All transactions
-
Grant·A
Director
$51.3K
587 sh · $87.40
Own +2%
-
Grant·A
Director
$14.5K
169 sh · $85.57
Own +1%
-
Grant·A
Director
$0
13.0K sh
Own +13%
-
Grant·A
Director
$0
2.1K sh
Own +15%
-
Grant·A
Director
$0
2.1K sh
Own +1%
-
Grant·A
Director
$0
2.1K sh
Own +35%
-
Grant·A
Director
$0
2.1K sh
Own +4%
-
Grant·A
Director
$0
2.1K sh
Own +39%
-
Grant·A
Director
$0
2.1K sh
Own +37%
-
Other·F
Chief Legal Officer
$44.9K
485 sh · $92.54
Own -1%
-
Other·F
Chief Accounting Officer
$691
8 sh · $86.39
Own -0%
-
Grant·A
CEO & President
$0
200.0K sh
Own +167%
-
Grant·A
CEO & President
$0
120.0K sh
Own New
-
Grant·A
Director
—
796 sh
Own +11%
-
Other·D
Director
—
796 sh
Own -25%
-
Grant·A
Director
$0
943 sh
Own +42%
-
Other·F
Chief Legal Officer
$5.9K
220 sh · $26.88
Own -0%
-
Other·F
Chief Technology Officer
$8.9K
330 sh · $26.88
Own -1%
-
Other·F
Chief Markets Officer
$15.3K
571 sh · $26.88
Own -0%
-
Other·F
Chief Accounting Officer
$3.3K
122 sh · $26.88
Own -1%
-
Other·F
Chief Legal Officer
$454
20 sh · $22.68
Own -0%
-
Other·F
Chief Technology Officer
$2.2K
96 sh · $22.68
Own -0%
-
Other·F
Chief Markets Officer
$2.4K
104 sh · $22.68
Own -0%
-
Other·F
Chief Accounting Officer
$567
25 sh · $22.68
Own -0%
-
Grant·A
Chief Legal Officer
$0
50.0K sh
Own +297%
-
Other·F
Chief Legal Officer
$10.0K
1.0K sh · $9.75
Own -6%
-
Grant·A
Chief Technology Officer
$0
28.0K sh
Own +263%
-
Other·F
Chief Technology Officer
$4.7K
480 sh · $9.75
Own -4%
-
Grant·A
Chief Markets Officer
$0
70.0K sh
Own +131%
-
Other·F
Chief Markets Officer
$16.2K
1.7K sh · $9.75
Own -3%
-
Grant·A
Chief Financial Officer
$0
75.0K sh
Own +115%
-
Other·F
Chief Financial Officer
$16.2K
1.7K sh · $9.75
Own -2%
-
Grant·A
Director
$51.3K
721 sh · $71.17
Own +3%
-
Grant·A
Chief Accounting Officer
$0
10.0K sh
Own +231%
-
Other·F
Chief Accounting Officer
$2.6K
266 sh · $9.75
Own -6%
| Date▾ | Insider | Type | Shares | Value |
|---|---|---|---|---|
| Jun 16, 2026 | Diana Mckenzie | Grant A | 587 | $51.3K |
| Jun 9, 2026 | Diana Mckenzie | Grant A | 169 | $14.5K |
| Jun 8, 2026 | Ronald A Williams | Grant A | 13.0K | $0 |
| Jun 2, 2026 | John William Wulf | Grant A | 2.1K | $0 |
| Jun 2, 2026 | Ronald A Williams | Grant A | 2.1K | $0 |
| Jun 2, 2026 | Karen Mcloughlin | Grant A | 2.1K | $0 |
| Jun 2, 2026 | Sharad Mansukani | Grant A | 2.1K | $0 |
| Jun 2, 2026 | Diana Mckenzie | Grant A | 2.1K | $0 |
| Jun 2, 2026 | Silvana Battaglia | Grant A | 2.1K | $0 |
| Jun 1, 2026 | Denise Zamore | Other F | 485 | $44.9K |
| May 24, 2026 | Timothy Gertsch | Other F | 8 | $691 |
| May 7, 2026 | Timothy Patrick O'Rourke KEY | Grant A | 200.0K | $0 |
| May 7, 2026 | Timothy Patrick O'Rourke KEY | Grant A | 120.0K | $0 |
| May 1, 2026 | Diana Mckenzie | Grant A | 796 | — |
| May 1, 2026 | Diana Mckenzie | Other D | 796 | — |
| May 1, 2026 | Diana Mckenzie | Grant A | 943 | $0 |
| Apr 15, 2026 | Denise Zamore | Other F | 220 | $5.9K |
| Apr 15, 2026 | Girish Venkatachaliah | Other F | 330 | $8.9K |
| Apr 15, 2026 | Benjamin Shaker | Other F | 571 | $15.3K |
| Apr 15, 2026 | Timothy Gertsch | Other F | 122 | $3.3K |
| Apr 14, 2026 | Denise Zamore | Other F | 20 | $454 |
| Apr 14, 2026 | Girish Venkatachaliah | Other F | 96 | $2.2K |
| Apr 14, 2026 | Benjamin Shaker | Other F | 104 | $2.4K |
| Apr 14, 2026 | Timothy Gertsch | Other F | 25 | $567 |
| Apr 1, 2026 | Denise Zamore | Grant A | 50.0K | $0 |
| Apr 1, 2026 | Denise Zamore | Other F | 1.0K | $10.0K |
| Apr 1, 2026 | Girish Venkatachaliah | Grant A | 28.0K | $0 |
| Apr 1, 2026 | Girish Venkatachaliah | Other F | 480 | $4.7K |
| Apr 1, 2026 | Benjamin Shaker | Grant A | 70.0K | $0 |
| Apr 1, 2026 | Benjamin Shaker | Other F | 1.7K | $16.2K |
| Apr 1, 2026 | Jeffrey A. Schwaneke KEY | Grant A | 75.0K | $0 |
| Apr 1, 2026 | Jeffrey A. Schwaneke KEY | Other F | 1.7K | $16.2K |
| Apr 1, 2026 | Diana Mckenzie | Grant A | 721 | $51.3K |
| Apr 1, 2026 | Timothy Gertsch | Grant A | 10.0K | $0 |
| Apr 1, 2026 | Timothy Gertsch | Other F | 266 | $2.6K |
About AGL insider trading
This page tracks insider transactions for agilon health, inc. (AGL) reported to the U.S. Securities and Exchange Commission on Form 4. Corporate insiders — directors, executive officers and beneficial owners of more than 10% of the stock — must disclose their trades within two business days. Open-market purchases (code P) and sales (code S) made at the insider's discretion are the most-watched opportunistic signals, while awards (A), option exercises (M) and tax-withholding (F) reflect compensation rather than conviction. Trades marked 10b5-1 were made under a pre-arranged plan and are considered routine. A cluster buy — several insiders buying within a short window — is historically a stronger bullish indicator than any single trade.